Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McKesson/Bristol relationship

Executive Summary

Wholesaler is negotiating with Bristol-Myers Squibb "discussing whether or not" an inventory management agreement "may work for us and for them," McKesson Supply Solutions President Paul Julian says during fiscal Q4 call April 29. The two companies currently are not operating under an IMA. Cardinal CEO Robert Walter has said the wholesaler believes BMS' new inventory management program undervalues Cardinal's current services (1"The Pink Sheet" April 28, p. 15)...

You may also be interested in...



Cardinal Wants New Deal With Bristol; Inventory Practices Reduce Rx Growth

Cardinal is renegotiating its arrangement with Bristol-Myers Squibb because the wholesaler feels the current deal undervalues its services

Individualized Gene Therapy: US FDA Considering Device-Like Manufacturing Approval Process

CBER Director Peter Marks said the agency could streamline development by allowing sponsors to depend on an already-approved manufacturing platform and reviewing any modifications that are proposed.

Faulty CDC COVID-19 Assays Leave Only 12 US Jurisdictions With Testing Ability, CDC Director Says

Only 12 US jurisdictions currently have sound COVID-19 virus assays from the Centers for Disease Control and Prevention to test suspected virus cases, CDC director Robert Redfield told a House panel looking at virus preparedness on Wednesday – but a better batch is coming, he said. Other questions raised at the congressional hearing was how long an infected person stays infected, whether COVID-19 can be picked up from inanimate surfaces, and related queries.

UsernamePublicRestriction

Register

PS041740

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel